封面
市場調查報告書
商品編碼
1057404

抗病毒藥物的市場規模、份額、前景、機會分析(2021-2028):按藥物類別、類型、用途、分銷渠道、地區

Antiviral Drugs Market, by Drug Class, by Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 189 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球抗病毒藥物市場的主要驅動力是艾滋病毒/艾滋病等病毒感染的日益流行。

本報告調查和分析全球抗病毒藥物市場、市場概況、市場促進劑/抑製劑分析、市場前景、COVID-19 的影響、按細分市場/地區分列的市場分析,它提供了競爭條件和概況等信息大公司。

目錄

第 1 章調查目標/先決條件

第二章市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
    • 市場細分:按藥物類別
    • 市場細分:按類型
    • 市場細分:按用途
    • 市場細分:按分銷渠道
    • 市場細分:按地區
  • 連貫的機會圖 (COM)

第三章市場動態、監管和趨勢分析

  • 促進因素
  • 抑制器
  • 市場機會
  • 影響分析
  • 管道分析
  • 監管場景
  • PEST 分析
  • 流行病學
  • 產品發布/批准
  • 主要發展
  • 兌換場景

第 4 章全球抗病毒藥物市場:COVID-19 大流行的影響

  • 對整個醫療保健市場的影響
  • 對抗病毒藥物的影響
  • 政府倡議

第 5 章全球抗病毒藥物市場(2017-2028):按藥物類別(100 萬美元)

  • 簡介
  • DNA聚合□抑製劑
  • 逆轉錄□抑製劑
  • 蛋白□抑□□製劑
  • 神經氨酸□抑製劑
  • 其他

第 6 章全球抗病毒藥物市場(2017-2028):按類型(100 萬美元)

  • 簡介
  • 品牌
  • 通用

第 7 章全球抗病毒藥物市場(2017-2028):按用途(100 萬美元)

  • 簡介
  • 艾滋病毒
  • 肝炎
  • 皰疹
  • 流感
  • 其他

第 8 章全球抗病毒藥物市場(2017-2028):按分銷渠道(100 萬美元)

  • 簡介
  • 醫院藥房
  • 零售藥店
  • 網上藥店

第 9 章全球抗病毒藥物市場(2017-2028):區域(100 萬美元)

  • 簡介
  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章競爭態勢

  • 快照
    • GlaxoSmithKline plc
    • AbbVie Inc.
    • Merck &Co., Inc.
    • Dr. Reddy's Laboratories Ltd.
    • F. Hoffmann-La Roche AG
    • Bristol-Myers Squibb Company
    • Johnson &Johnson Services, Inc.
    • Cipla Inc.
    • Aurobindo Pharma
    • Gilead Sciences

第11章 章節

簡介目錄
Product Code: CMI4912

Antiviral drugs are prescription medicine such as pills, liquid, or intravenous solution to treat HIV, hepatitis B and C viruses, influenza A and B viruses, and herpes viruses. Antiviral drugs are different from antibiotics, which fight against bacterial infections.

Furthermore, the global antiviral drugs market is driven by increasing prevalence of viral infection such as HIV/AIDS. For instance, according to the report of Joint United Nations Programme (UNAIDS) (2021), there were 37.9 million people suffering from HIV/AIDS and around 770,000 people died from this disease globally in 2020.

Market Dynamics

Key players are focusing on product approvals to strengthen their position in the global antiviral drugs market.

For instance, in April 2021, Zydus Cadila, a pharmaceutical company has received Drug Controller General of India (DCGI) approval for its antiviral drug Virafin for the treatment of moderate COVID-19 infection in adults.

Key features of the study:

  • This report provides in-depth analysis of the global antiviral drugs market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global antiviral drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline plc, AbbVie Inc., Merck & Co., Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Cipla Inc., Aurobindo Pharma, and Gilead Sciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global antiviral drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antiviral drugs market

Detailed Segmentation:

  • Global Antiviral Drugs Market, By Drug Class:
    • DNA Polymerase Inhibitors
    • Reverse Transcriptase Inhibitors
    • Protease Inhibitors
    • Neuraminidase Inhibitors
    • Others
  • Global Antiviral Drugs Market, By Type:
    • Branded
    • Generics
  • Global Antiviral Drugs Market, By Application:
    • HIV
    • Hepatitis
    • Herpes
    • Influenza
    • Others
  • Global Antiviral Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Antiviral Drugs Market, By Region:
    • North America
      • By Drug Class
      • DNA Polymerase Inhibitors
      • Reverse Transcriptase Inhibitors
      • Protease Inhibitors
      • Neuraminidase Inhibitors
      • Others
      • By Type
      • Branded
      • Generics
      • By Application
      • HIV
      • Hepatitis
      • Herpes
      • Influenza
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Drug Class
      • DNA Polymerase Inhibitors
      • Reverse Transcriptase Inhibitors
      • Protease Inhibitors
      • Neuraminidase Inhibitors
      • Others
      • By Type
      • Branded
      • Generics
      • By Application
      • HIV
      • Hepatitis
      • Herpes
      • Influenza
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Class
      • DNA Polymerase Inhibitors
      • Reverse Transcriptase Inhibitors
      • Protease Inhibitors
      • Neuraminidase Inhibitors
      • Others
      • By Type
      • Branded
      • Generics
      • By Application
      • HIV
      • Hepatitis
      • Herpes
      • Influenza
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Class
      • DNA Polymerase Inhibitors
      • Reverse Transcriptase Inhibitors
      • Protease Inhibitors
      • Neuraminidase Inhibitors
      • Others
      • By Type
      • Branded
      • Generics
      • By Application
      • HIV
      • Hepatitis
      • Herpes
      • Influenza
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Class
      • DNA Polymerase Inhibitors
      • Reverse Transcriptase Inhibitors
      • Protease Inhibitors
      • Neuraminidase Inhibitors
      • Others
      • By Type
      • Branded
      • Generics
      • By Application
      • HIV
      • Hepatitis
      • Herpes
      • Influenza
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Class
      • DNA Polymerase Inhibitors
      • Reverse Transcriptase Inhibitors
      • Protease Inhibitors
      • Neuraminidase Inhibitors
      • Others
      • By Type
      • Branded
      • Generics
      • By Application
      • HIV
      • Hepatitis
      • Herpes
      • Influenza
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • GlaxoSmithKline plc *
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • AbbVie Inc.
    • Merck & Co., Inc.
    • Dr. Reddy's Laboratories Ltd.
    • F. Hoffmann-La Roche AG
    • Bristol-Myers Squibb Company
    • Johnson & Johnson Services, Inc.
    • Cipla Inc.
    • Aurobindo Pharma
    • Gilead Sciences

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Pipeline Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Epidemiology
  • Product Launch/Approvals
  • Key Developments
  • Reimbursement Scenario

4. Global Antiviral Drugs Market - Impact of Coronavirus (Covid-19) Pandemic

  • COVID-19 Impact on Overall Healthcare Market
  • Impact Of Antiviral Drugs
  • Government Initiative To Combat Covid-19

5. Global Antiviral Drugs Market, By Drug Class, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • DNA Polymerase Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Reverse Transcriptase Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Protease Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Neuraminidase Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Antiviral Drugs Market, By Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Generics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Antiviral Drugs Market, By Application, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • HIV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Hepatitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Herpes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Antiviral Drugs Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

9. Global Antiviral Drugs Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2028
  • North America
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Competitive Snapshot
    • GlaxoSmithKline plc *
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol-Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson Services, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cipla Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aurobindo Pharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Gilead Sciences
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact